|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Y-mAbs Therapeutics (NASDAQ: YMAB) through any online brokerage.
The latest price target for Y-mAbs Therapeutics (NASDAQ: YMAB) was reported by JP Morgan on March 22, 2021. The analyst firm set a price target for 52.00 expecting YMAB to rise to within 12 months (a possible 52.00% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Y-mAbs Therapeutics (NASDAQ: YMAB) is $34.21 last updated Wed Jun 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Y-mAbs Therapeutics.
There is no upcoming split for Y-mAbs Therapeutics.
Y-mAbs Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.